BioWorld

Jan. 6, 2005

Gathering Steam, Infinity Signs Deals With Novartis, J&J Unit

In rapid succession, Infinity Pharmaceuticals Inc. announced its second and third collaborations, forming with two pharmaceutical companies agreements that include equity investments. (BioWorld Today) Read More

Keryx Planning Pivotal Work For KRX-101 After Interim Analysis

Psoriasis Research: Pendulum Now Swings Back To Skin Cells

NeoPharm Partners Late-Stage Glioblastoma Product In Japan

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...

Flow Neuro wins FDA nod for at-home device for depression

BioWorld MedTech

Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...